CompletedNot Applicable

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

South Korea17,286 participantsStarted 2008-04-01

Plain-language summary

The objective of this study is to evaluate the long-term efficacy and safety of coronary stenting with the various types of drug-eluting stents (DES) and to determine clinical device and procedural success during commercial use of DES in the real world. The investigators will compare EES (Xience V/Promus and Xience Prime), SES (Cypher), ZES (Resolute Integrity, Endeavor Resolute, Endeavor), and BES (Biomatrix, Biomatrix Flex, and Nobori).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient agrees to participate in this study by signing the informed consent form. * Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form. Exclusion Criteria: * There are no exclusion criteria for this registry.

What they're measuring

Target lesion failure

Timeframe: 36 months

Trial details

NCT IDNCT03507205

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-11-01

View on ClinicalTrials.gov More Coronary Artery Disease trials